Modeling the oxidation of methionine residues by peroxides in proteins.
暂无分享,去创建一个
Stanley Krystek | Yong Quan | Olav Lyngberg | Vishal Nashine | Olav K. Lyngberg | V. Nashine | Naresh Chennamsetty | S. Krystek | Naresh Chennamsetty | Vikram Sadineni | Yong Quan | Vikram Sadineni
[1] W R Markesbery,et al. Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.
[2] R. Dean,et al. Biochemistry and pathology of radical-mediated protein oxidation. , 1997, The Biochemical journal.
[3] E. Stadtman,et al. Methionine residues as endogenous antioxidants in proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[4] Bernhardt L Trout,et al. Molecular dynamics simulations and oxidation rates of methionine residues of granulocyte colony-stimulating factor at different pH values. , 2004, Biochemistry.
[5] W. Vogt. Oxidation of methionyl residues in proteins: tools, targets, and reversal. , 1995, Free radical biology & medicine.
[6] H. Friesen,et al. Methionine oxidation in human growth hormone and human chorionic somatomammotropin. Effects on receptor binding and biological activities. , 1987, The Journal of biological chemistry.
[7] Bernard R Brooks,et al. A comprehensive picture of non-site specific oxidation of methionine residues by peroxides in protein pharmaceuticals. , 2004, Journal of pharmaceutical sciences.
[8] Bernhardt L Trout,et al. A structural and mechanistic study of the oxidation of methionine residues in hPTH(1-34) via experiments and simulations. , 2004, Biochemistry.
[9] T. Nguyen,et al. The Kinetics of Relaxin Oxidation by Hydrogen Peroxide , 1993, Pharmaceutical Research.
[10] C. Schöneich,et al. Oxidative degradation of pharmaceuticals: theory, mechanisms and inhibition. , 2001, Journal of pharmaceutical sciences.
[11] R T Borchardt,et al. Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization. , 1995, Biotechnology and bioengineering.
[12] E. Stadtman,et al. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. , 1993, Annual review of biochemistry.
[13] Krzysztof Fidelis,et al. CASP10 results compared to those of previous CASP experiments , 2014, Proteins.
[14] B. Brooks,et al. Oxidation of methionine residues in aqueous solutions: free methionine and methionine in granulocyte colony-stimulating factor. , 2004, Journal of the American Chemical Society.
[15] B. Kerwin. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. , 2008, Journal of pharmaceutical sciences.
[16] C. Schöneich,et al. Loss of conformational stability in calmodulin upon methionine oxidation. , 1998, Biophysical journal.
[17] Bernhardt L Trout,et al. Comparative oxidation studies of methionine residues reflect a structural effect on chemical kinetics in rhG-CSF. , 2006, Biochemistry.
[18] Gang Huang,et al. Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn , 2009, Protein science : a publication of the Protein Society.
[19] V. Uversky,et al. Role of individual methionines in the fibrillation of methionine-oxidized α-synuclein , 2004 .
[20] Krzysztof Fidelis,et al. CASP9 results compared to those of previous casp experiments , 2011, Proteins.
[21] D. Brems,et al. Oxidation of methionine residues in recombinant human interleukin-1 receptor antagonist: implications of conformational stability on protein oxidation kinetics. , 2007, Biochemistry.
[22] Bernhardt L Trout,et al. On the mechanisms of oxidation of organic sulfides by H2O2 in aqueous solutions. , 2004, Journal of the American Chemical Society.
[23] Charles L. Cooney,et al. Relationship between Protein Structure and Methionine Oxidation in Recombinant Human α1-Antitrypsin , 2002 .
[24] Hui Xu,et al. Evaluation of hydroperoxides in common pharmaceutical excipients. , 2007, Journal of pharmaceutical sciences.
[25] Brian M. Murphy,et al. Stability of Protein Pharmaceuticals: An Update , 2010, Pharmaceutical Research.
[26] B. Lee,et al. The interpretation of protein structures: estimation of static accessibility. , 1971, Journal of molecular biology.
[27] W. Stites,et al. Comparing the effect on protein stability of methionine oxidation versus mutagenesis: steps toward engineering oxidative resistance in proteins. , 2001, Protein engineering.
[28] J L Cleland,et al. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.
[29] E. Stadtman. Role of oxidant species in aging. , 2004, Current medicinal chemistry.
[30] W Wang,et al. Instability, stabilization, and formulation of liquid protein pharmaceuticals. , 1999, International journal of pharmaceutics.
[31] Riccardo Torosantucci,et al. Oxidation of Therapeutic Proteins and Peptides: Structural and Biological Consequences , 2014, Pharmaceutical Research.